196 related articles for article (PubMed ID: 27895220)
1. Patient perspectives on the barriers associated with medication adherence to oral chemotherapy.
Muluneh B; Deal A; Alexander MD; Keisler MD; Markey JM; Neal JM; Bernard S; Valgus J; Dressler LG
J Oncol Pharm Pract; 2018 Mar; 24(2):98-109. PubMed ID: 27895220
[TBL] [Abstract][Full Text] [Related]
2. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
3. Adherence to targeted oral anticancer medications.
Geynisman DM; Wickersham KE
Discov Med; 2013 Apr; 15(83):231-41. PubMed ID: 23636140
[TBL] [Abstract][Full Text] [Related]
4. Treatment Satisfaction and Adherence to Oral Chemotherapy in Patients With Cancer.
Jacobs JM; Pensak NA; Sporn NJ; MacDonald JJ; Lennes IT; Safren SA; Pirl WF; Temel JS; Greer JA
J Oncol Pract; 2017 May; 13(5):e474-e485. PubMed ID: 28398843
[TBL] [Abstract][Full Text] [Related]
5. Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol.
Yeager KA; Waldrop-Valverde D; Paul S; Bruner DW; Klisovic R; Burns E; Mason TA; Patel N; Jennings BM
Res Nurs Health; 2020 Sep; 43(5):443-452. PubMed ID: 32866350
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study.
Davis TC; Arnold CL; Mills G; Lesser GJ; Brown WM; Schulz R; Weaver KE; Pawloski PA
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769563
[TBL] [Abstract][Full Text] [Related]
7. Lack of congruence between patients' and health professionals' perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative study.
Wu S; Chee D; Ugalde A; Butow P; Seymour J; Schofield P
Palliat Support Care; 2015 Apr; 13(2):255-63. PubMed ID: 24524212
[TBL] [Abstract][Full Text] [Related]
8. Failure mode and effects analysis of medication adherence in patients with chronic myeloid leukemia.
Hosoya K; Mochinaga S; Emoto A; Yokoo H; Tokushima H; Egoshi M; Sueoka-Aragane N; Kimura S
Int J Clin Oncol; 2015 Dec; 20(6):1203-10. PubMed ID: 26002407
[TBL] [Abstract][Full Text] [Related]
9. Exploring behaviors, treatment beliefs, and barriers to oral chemotherapy adherence among adult leukemia patients in a rural outpatient setting.
Lea CS; Bohra S; Moore T; Passwater C; Liles D
BMC Res Notes; 2018 Nov; 11(1):843. PubMed ID: 30497510
[TBL] [Abstract][Full Text] [Related]
10. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
Lam MS; Cheung N
J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
[TBL] [Abstract][Full Text] [Related]
11. [Anticancer drug adherence].
Despas F; Roche H; Laurent G
Bull Cancer; 2013 May; 100(5):473-84. PubMed ID: 23694959
[TBL] [Abstract][Full Text] [Related]
12. Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
Bourmaud A; Henin E; Tinquaut F; Regnier V; Hamant C; Colomban O; You B; Ranchon F; Guitton J; Girard P; Freyer G; Tod M; Rioufol C; Trillet-Lenoir V; Chauvin F
BMC Res Notes; 2015 Jul; 8():291. PubMed ID: 26142140
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
14. Conflicting meal recommendations for oral oncology drugs: pose risks to patient care?
Yu G; Wu DN; Gong Y; Li GF; Zhou HH
Eur J Clin Pharmacol; 2018 Jun; 74(6):833-842. PubMed ID: 29536134
[TBL] [Abstract][Full Text] [Related]
15. Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia.
Gater A; Heron L; Abetz-Webb L; Coombs J; Simmons J; Guilhot F; Rea D
Leuk Res; 2012 Jul; 36(7):817-25. PubMed ID: 22364811
[TBL] [Abstract][Full Text] [Related]
16. Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors.
Epstein RS; Aapro MS; Basu Roy UK; Salimi T; Krenitsky J; Leone-Perkins ML; Girman C; Schlusser C; Crawford J
Adv Ther; 2020 Aug; 37(8):3606-3618. PubMed ID: 32642965
[TBL] [Abstract][Full Text] [Related]
17. Oral chemotherapy food and drug interactions: a comprehensive review of the literature.
Segal EM; Flood MR; Mancini RS; Whiteman RT; Friedt GA; Kramer AR; Hofstetter MA
J Oncol Pract; 2014 Jul; 10(4):e255-68. PubMed ID: 24756141
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries.
Geissler J; Sharf G; Bombaci F; Daban M; De Jong J; Gavin T; Pelouchova J; Dziwinski E; Hasford J; Hoffmann VS
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1167-1176. PubMed ID: 28289895
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Peer Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.
Kanters AE; Morris AM; Abrahamse PH; Mody L; Suwanabol PA
Dis Colon Rectum; 2018 Jul; 61(7):817-823. PubMed ID: 29771795
[TBL] [Abstract][Full Text] [Related]
20. Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia.
Goldberg SL; Akard LP; Dugan MJ; Faderl S; Pecora AL
J Oncol Pract; 2015 May; 11(3):e398-404. PubMed ID: 25758446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
